Dr Roy Chowdhury is the clinical trial administrator of Saroj Gupta Cancer Centre and Research Institute, Thakurpukur, Kolkata. Here he plays a pivotal role in driving both clinical and academic research trials in the institute.
He is a keen researcher and collaborates on various projects with scientists from National Institute of Bio Medical Genomics (NIBMG), Kalyani, Indian Institute of Chemical Biology, Jadavpur, Kolkata and various departments of University of Calcutta.
At present he is involved in the following projects:
- A prospective non-randomised trial of Squamous Cell Carcinoma of cervix uteri of stage IB2, IIA, IIB pretreated with three cycles of Neo Adjuvant Chemotherapy (NACT) followed by surgery after down-staging to stage IB1 followed by active surveillance. Dr N R Mondal, Dr R Roy Chowdhury, Dr Biman Chakrabarti, Dr T Chatterjee, Dr J Basak (Dept of Gynaecological Oncology SGCCRI)
- Variation in human gene expression among women from four states of India: genomic correlates, gene regulation and impact on HPV16 related cervical cancer pathogenesis. Dr Sharmila Sengupta, National Institute of Biomedical Genomics, Kalyani, Dr N R Mondal , Dr R Roy Chowdhury (Dept of Gynaeoncology), SGCCRI, Thakurpukur
- Association of genetic polymorphism of matrix metalloproteinases (MMPs) and their expression in epithelial ovarian cancer. Dr Susri Ray Chaudhuri PhD (Research Associate), IICB, Dr Snehaswikta Swarnakar, Senior Scientist IICB, Dr Rahul Roy Chowdhury MRCOG, SGCCRI Thakurpukur [ ICMR funded project]
- HPV 16 Methylome, methylation and gene expression status of host genes: influence on cervical cancer pathogenesis.- Dr Rahul Roy Chowdhury, SGCCRI and Dr Sharmila Sengupta NIBMG
- A Phase II Clinical Study to evaluate the efficacy and safety of NRC – AN – 019 in cancer patients failing standard prior therapies – Dr Samir Bhattacharyya, SGCCRI, Dr R N Ghosh, Dr Arnab Gupta, Dr Saradindu Ghosh, Dr Rakesh Roy, Dr Rahul Roy Chowdhury.
- HPV 16 Methylome, methylation and gene expression status of host genes: influence on cervical cancer pathogenesis.- Dr Rahul Roy Chowdhury, SGCCRI and Dr Sharmila Sengupta NIBMG
Ongoing Trial:
- 1. A phase III multicentre trial of weekly induction chemotherapy followed by standard
chemo-radiation versus standard chemo-radiation alone in patients with locally
advanced cervical cancer [INTERLACE] – SITE PI in an International Academic Trial.
Sponsor-University College London and Cancer Research, UK.
- 2. Integrating Multi-Omics Data Using Big data analytic to infer optimal wellness
trajectories for management of non-communicable disease (NCDs): cervical cancer as an
exemplar – Co – I , Academic Trial, Flagship project of National Institute of Bio-medical
Genomics, Sponsor: DBT
GCP- Refresher Good Clinical Practice Refresher Certificate
